Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 39 citing articles:

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses
Giuseppe A. Ramirez, Marco Ripa, Samuele E. Burastero, et al.
Microorganisms (2023) Vol. 11, Iss. 2, pp. 346-346
Open Access | Times Cited: 24
Severe cutaneous adverse reactions to drugs: A real-world pharmacovigilance study using the FDA Adverse Event Reporting System database
Dongxuan Li, Jinghui Gou, Jun Zhu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 17
Pustular Psoriasis and Acute Generalized Exanthematous Pustulosis
Morgan Sussman, Anthony Napodano, Simo Huang, et al.
Medicina (2021) Vol. 57, Iss. 10, pp. 1004-1004
Open Access | Times Cited: 29
Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome in childhood: a narrative review
Elisa Manieri, Arianna Dondi, Iria Neri, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 12
Medication Associations With Severe Cutaneous Adverse Reactions: A Case/Non-Case Analysis Using the FDA Adverse Event Reporting System
Hannah Godfrey, Patrick Jedlowski, Rebecca Thiede
Journal of Cutaneous Medicine and Surgery (2024) Vol. 28, Iss. 1, pp. 51-58
Closed Access | Times Cited: 4
Severe cutaneous adverse reactions associated with the immune checkpoint inhibitors: A case/non‐case analysis using the Food and Drug Administration Adverse Event Reporting System
Hannah Godfrey, Patrick Jedlowski, Rebecca Thiede
Australasian Journal of Dermatology (2024) Vol. 65, Iss. 3, pp. 243-253
Closed Access | Times Cited: 4
Latin American guidelines for the diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis
Andrea Dionelly Murillo-Casas, Ricardo Zwiener, Pedro Giavina‐Bianchi, et al.
World Allergy Organization Journal (2025) Vol. 18, Iss. 4, pp. 101046-101046
Open Access
Síndrome de Steven Jhonson / Necrólisis epidérmica tóxica: revisión de literatura y actualización
J. Martínez, Daysi Lorena Daysi Lorena Caiza López, Roberto José Bonfante Villalobos, et al.
Medicina (2025) Vol. 46, Iss. 3, pp. 729-741
Open Access
Causes and Management of Cutaneous Adverse Drug Reactions: A Comprehensive Review
Arsh Sutaria, Shobha Rawlani, Amita Sutaria
Cureus (2024)
Open Access | Times Cited: 2
Severe cutaneous adverse reactions due to antibiotics therapy: a pharmacovigilance analysis of FDA adverse event reporting system events
Lu Zhou, Jing Yang, Min Xiao, et al.
Expert Opinion on Drug Safety (2023), pp. 1-8
Closed Access | Times Cited: 6
Current understanding of genetic associations with delayed hypersensitivity reactions induced by antibiotics and anti-osteoporotic drugs
Chih-Hsuan Wung, Chuang‐Wei Wang, Kuo‐Chu Lai, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 5
Stevens-johnson Syndrome and Toxic Epidermal Necrolysis: An Overview of Diagnosis, Therapy Options and Prognosis of Patients
Vivek Kumar Garg, Harpal S. Buttar, Sajad Ahmad Bhat, et al.
Recent Advances in Inflammation & Allergy Drug Discovery (2023) Vol. 17, Iss. 2, pp. 110-120
Closed Access | Times Cited: 5
Signal mining study of severe cutaneous adverse events of valaciclovir or acyclovir based on the FAERS database
Kaili Mao, Li Jiang, Xinliang Zhu, et al.
Expert Review of Clinical Pharmacology (2023) Vol. 17, Iss. 1, pp. 101-110
Closed Access | Times Cited: 5
A Review of Bullous Dermatologic Adverse Events Associated with Anti-Cancer Therapy
Rose Parisi, Hemali Shah, Neil H. Shear, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 323-323
Open Access | Times Cited: 4
Toxic epidermal necrolysis complicated with respiratory failure in children: A case report
Xiaoqian Chen, Suhua Jiang
Heliyon (2024) Vol. 10, Iss. 4, pp. e25830-e25830
Open Access | Times Cited: 1
A Bayesian Network Meta-Analysis of the Effect of Targeted Therapies on the Total Length of Hospital Stay in Children with Drug-Induced Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis Syndrome
Sahure ÖZERTÜRK, Didem Derici Yıldırım, Tuğba Arıkoğlu, et al.
Pediatric Allergy Immunology and Pulmonology (2024) Vol. 37, Iss. 1, pp. 22-32
Closed Access | Times Cited: 1
High risk and low prevalence diseases: Stevens Johnson syndrome and toxic epidermal necrolysis
Christiaan van Nispen, Brit Long, Alex Koyfman
The American Journal of Emergency Medicine (2024) Vol. 81, pp. 16-22
Closed Access | Times Cited: 1
Antibiotic-induced severe cutaneous adverse reactions: a single-center retrospective study over ten years
Yun Lu, Lu Zhou, Ya Zou, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Differences in safety profiles of anti-herpesvirus medications: a real-world pharmacovigilance study based on the FAERS database
He Dan, Dexuan Kong, Yanbin Zeng, et al.
Expert Opinion on Drug Safety (2024), pp. 1-10
Closed Access | Times Cited: 1
Death Due to Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Case Report
Samantha P Sternad, Jane Pangburn, Chad Johnston, et al.
HCA Healthcare Journal of Medicine (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 2
A real-world pharmacovigilance study of severe cutaneous adverse reactions associated with antiepileptic drug combination therapy: data mining of FDA adverse event reporting system
Chunyan Wei, Jingyi Zhang, Wanhong Yin, et al.
Expert Opinion on Drug Safety (2022) Vol. 22, Iss. 6, pp. 509-515
Open Access | Times Cited: 4
Clinical features and prognostic factors of severe cutaneous adverse drug reactions: A single-center retrospective study of 209 cases in China
Min Deng, Yu‐Wen Su, Ruifang Wu, et al.
International Immunopharmacology (2022) Vol. 114, pp. 109530-109530
Closed Access | Times Cited: 4
Diffuse Rash Followed by Erosions on the Lips and Mouth
Patricia Larrieu-Jimenez, Juan M. González, Nichole Crenshaw, et al.
The Journal for Nurse Practitioners (2023) Vol. 19, Iss. 10, pp. 104802-104802
Closed Access | Times Cited: 2
Eosinophilic pustular folliculitis due to naltrexone: A case report
Sarah Smith, Nicole Cernaro, Erica Tonti
Journal of the American Pharmacists Association (2022) Vol. 62, Iss. 6, pp. 1925-1928
Closed Access | Times Cited: 3
Drug reaction with eosinophilia and systemic symptoms: Analysis of cutaneous phenotype as a prognosis factor
G. Sqalli-Houssini, Zakia Douhi, Meryem Soughi, et al.
Revue française d'allergologie (2024) Vol. 64, Iss. 6, pp. 104161-104161
Closed Access
Page 1 - Next Page

Scroll to top